NuCana
NCNA
#10611
Rank
A$10.96 M
Marketcap
A$2.63
Share price
-0.54%
Change (1 day)
-93.09%
Change (1 year)

Earnings for NuCana (NCNA)

Earnings in 2025 (TTM): -A$39.88 Million

According to NuCana 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$41.93 Million, an increase over its 2023 earnings that were of -A$55.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NuCana from 2017 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$39.88 Million-4.89%
2024 -A$41.93 Million-24.16%
2023 -A$55.28 Million-27.12%
2022 -A$75.85 Million-13.88%
2021 -A$88.07 Million45.6%
2020 -A$60.49 Million29.44%
2019 -A$46.73 Million12.74%
2018 -A$41.45 Million-8.89%
2017 -A$45.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 450.75%๐Ÿ‡บ๐Ÿ‡ธ USA